Boothbay Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$617K Sell
1,755
-13,279
-88% -$4.73M 0.01% 1229
2025
Q4
$4.92M Buy
15,034
+10,507
+232% +$3.33M 0.07% 290
2025
Q3
$1.28M Buy
4,527
+1,918
+74% +$556K 0.02% 733
2025
Q2
$728K Buy
+2,609
New +$739K 0.01% 787
2024
Q4
Sell
-3,670
Closed -$1.09M 1471
2024
Q3
$1.18M Sell
3,670
-6,530
-64% -$2.14M 0.03% 705
2024
Q2
$3.19M Buy
+10,200
New +$3M 0.08% 347
2022
Q4
Sell
-1,912
Closed -$431K 1980
2022
Q3
$431K Buy
+1,912
New +$463K 0.01% 1307
2022
Q2
Sell
-2,453
Closed -$601K 2224
2022
Q1
$593K Buy
+2,453
New +$564K 0.01% 1196
2021
Q4
Sell
-2,266
Closed -$482K 1836
2021
Q3
$482K Buy
+2,266
New +$522K 0.01% 1106
2017
Q2
Sell
-6,307
Closed -$1.03M 661
2017
Q1
$1.03M Buy
6,307
+4,478
+245% +$744K 0.19% 122
2016
Q4
$267 Sell
1,829
-1,217
-40% -$183K 0.06% 452
2016
Q3
$508K Buy
3,046
+1,448
+91% +$245K 0.11% 209
2016
Q2
$243K Buy
+1,598
New +$248K 0.09% 311
2016
Q1
Sell
-2,243
Closed -$364K 306
2015
Q4
$364K Sell
2,243
-775
-26% -$122K 0.16% 202
2015
Q3
$417K Buy
+3,018
New +$476K 0.2% 102

Other funds holding AMGN

Boothbay Fund Management's AMGN Position: Q1 2026 in Review

Boothbay Fund Management reduced its Amgen (AMGN) stake by 88% in Q1 2026, selling an estimated $4.73M and leaving 1,755 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #1229.

Boothbay Fund Management first reported a position in AMGN in Q3 2015 and has held it in 15 quarters since. The position peaked at $4.92M in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Boothbay Fund Management held 1,755 shares of Amgen worth $617K as of Q1 2026.
  • Boothbay Fund Management sold 13,279 Amgen shares in Q1 2026, an estimated $4.73M.
  • Amgen made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1229 holding.
  • Boothbay Fund Management first reported a position in Amgen in Q3 2015 and has held it in 15 quarters since.
  • Boothbay Fund Management's Amgen position peaked at $4.92M in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.